For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Coley Pharmaceutical Group, Inc.

USPTO Granted Patents = 41

CIPO Patents = 14

EPO Patents = 11

Forward Citations = 1,575

Loading Chart...

Loading Chart...

82 inventors (with patents filed for the assignee):

Arthur Mertz Krieg (28 out of 68 patents)

Dennis M Klinman (12 out of 54 patents)

Alfred D Steinberg (12 out of 15 patents)

4. Jörg Vollmer (11 out of 16 patents)

5. Eugen Uhlmann (8 out of 80 patents)

6. Grayson B Lipford (5 out of 23 patents)

7. Ulrike Samulowitz (5 out of 5 patents)

8. Joel N Kline (4 out of 13 patents)

9. Tushar A Kshirsagar (3 out of 48 patents)

10. Heather Lynn Davis (3 out of 16 patents)

11. Robert L Bratzler (3 out of 6 patents)

12. Marion Jurk (3 out of 10 patents)

13. Philip D Heppner (3 out of 64 patents)

14. Alexandra Forsbach (3 out of 3 patents)

15. George W Griesgraber (2 out of 106 patents)

41 patents: Sort by Forward Citations

1. 9453059 - Immunostimulatory oligonucleotides (2016-09-27),

2. 9205143 - Pneumococcal vaccine and uses thereof (2015-12-08),

3. 8354522 - Immunostimulatory oligoribonucleotides (2013-01-15),

4. 8309527 - Immunomodulatory oligonucleotides (2012-11-13),

5. 8304396 - Immunostimulatory nucleic acids (2012-11-06),

6. 8283328 - Immunostimulatory nucleic acids (2012-10-09),

7. 8258106 - Immunostimulatory nucleic acid molecules (2012-09-04),

8. 8198251 - Combination motif immune stimulatory oligonucleotides with improved activity (2012-06-12),

9. 8188254 - C-class oligonucleotide analogs with enhanced immunostimulatory potency (2012-05-29),

10. 8158592 - Immunostimulatory nucleic acid molecules (2012-04-17),

11. 8129351 - Immunostimulatory nucleic acid molecules (2012-03-06),

12. 8114848 - Immunomodulatory oligonucleotides (2012-02-14),

13. 8114419 - Nucleic acid compositions for stimulating immune responses (2012-02-14),

14. 8058249 - Immunostimulatory nucleic acid molecules (2011-11-15),

15. 8008266 - Methods of treating cancer using immunostimulatory oligonucleotides (2011-08-30),

Coley Pharmaceutical Group, Inc. is a leading biotechnology company dedicated to the discovery and development of innovative immunotherapy drugs. Our mission is to harness the power of the immune system to fight against cancer and other diseases. With a team of world-class scientists and state-of-the-art facilities, we are committed to delivering breakthrough therapies that have the potential to transform patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

41 Patents

#190 in New York, NY

#466 in New York

#8,156 in US

#16,191 in the World

New York, NY, United States of America

Coley Pharmaceutical Group, Inc.

Forward Citations = 1,575

82 inventors:

Arthur Mertz Krieg (28 out of 68 patents)

Dennis M Klinman (12 out of 54 patents)

Alfred D Steinberg (12 out of 15 patents)

4. Jörg Vollmer (11 out of 16 patents)

5. Eugen Uhlmann (8 out of 80 patents)

Please report any incorrect information to support@idiyas.com

Loading…